A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
By Guest Columnist Dr. Stephanie Duguid Our most recent speaker through the Mississippi Health Ambassador Initiative was Dr.
Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain.
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
NEW YORK — Sean “Diddy” Combs pleaded not guilty to a revised indictment in his sex trafficking and racketeering case Friday, including allegations he threatened employees into working ...
The midpoint demonstrates ~32% growth YoY, fueled by new Lilly medicines like Zepbound, Mounjaro, Jaypirca, Ebglyss, Omvoh and Kisunla, approvals of new indications for existing Lilly medicines ...
“Working together with Re:Cognition Health, we can help patients quickly learn about and gain access to relevant clinical trials as well as the latest FDA-approved treatments (Leqembi and ...
Treatment with donanemab (Kisunla) raised the risk of amyloid-related ... which also include lecanemab (Leqembi). The donanemab secondary analysis "largely reinforces some of the key observations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback